Vaddi Krishna Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
15
Insider Buys Sum
$873,725.76
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Vaddi Krishna

Biography of Vaddi Krishna

No biography is available at this moment.

2025-03-25PurchasePrelude Therapeutics Incorporated
PRLD
CEO
675,000
1.2187%
$0.69$467,438+79.75%
2025-03-21PurchasePrelude Therapeutics Incorporated
PRLD
CEO
15,000
0.028%
$0.73$10,959+72.39%
2025-03-20PurchasePrelude Therapeutics Incorporated
PRLD
CEO
5,416
0.0097%
$0.73$3,950+65.65%
2025-03-17PurchasePrelude Therapeutics Incorporated
PRLD
CEO
9,106
0.0164%
$0.75$6,829+60.29%
2025-03-14PurchasePrelude Therapeutics Incorporated
PRLD
CEO
29,999
0.0447%
$0.75$22,631+61.12%
2025-03-13PurchasePrelude Therapeutics Incorporated
PRLD
CEO
50,000
0.0921%
$0.72$35,820+68.34%
2025-03-12PurchasePrelude Therapeutics Incorporated
PRLD
CEO
47,500
0.0881%
$0.71$33,744+70.93%
2024-12-31PurchasePrelude Therapeutics Incorporated
PRLD
CEO
5,000
0.0087%
$1.21$6,044-21.86%
2024-12-30PurchasePrelude Therapeutics Incorporated
PRLD
CEO
10,000
0.0163%
$1.20$12,000-17.99%
2024-12-19PurchasePrelude Therapeutics Incorporated
PRLD
CEO
6,888
0.0122%
$0.89$6,116+11.75%
2024-12-18PurchasePrelude Therapeutics Incorporated
PRLD
CEO
100,000
0.1882%
$0.93$93,210+8.51%
2023-05-25PurchasePrelude Therapeutics Incorporated
PRLD
CEO
900
0.0019%
$5.31$4,779-28.14%
2023-05-24PurchasePrelude Therapeutics Incorporated
PRLD
CEO
1,000
0.002%
$5.01$5,011-26.55%
2023-05-23PurchasePrelude Therapeutics Incorporated
PRLD
CEO
11,856
0.0257%
$5.63$66,749-30.46%
2022-12-20PurchasePrelude Therapeutics Incorporated
PRLD
CEO
19,188
0.0417%
$5.13$98,446-6.63%
Total: 15
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.